Recent News About Prettybrook and Friends
Dynatronics Corporation announced today the appointment of David A. Wirthlin as Chief Financial Officer (CFO), effective October 11, 2016. Wirthlin will succeed Terry M. Atkinson and will report to Dynatronics' CEO Kelvyn H. Cullimore, Jr. Mr. Atkinson will continue with Dynatronics as Director of Accounting.
Dynatronics Corporation today announced its fourth quarter results and financial results for the fiscal year ended June 30, 2016. Net sales for the quarter increased 2.8 percent to $8.1 million, compared to $7.9 million in the same period of the prior year. Gross profit for the quarter increased 45.1 percent representing 33.0 percent of sales, compared to 23.4 percent of sales for the quarter ended June 30, 2015.
Breg, Inc., a premier provider of integrated solutions that help improve the quality and lower the cost of the orthopedic episode, today announced the launch of Vision™ 5.0 — the latest iteration of its Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) workflow management software. Vision automates and optimizes in-house bracing and supplies programs.
TPG Capital, the North American- and European-focused private equity fund of leading global alternative asset firm TPG, today announced it has entered into a definitive agreement to purchase Beaver-Visitec International ("BVI" or the "Company") from RoundTable Healthcare Partners ("RoundTable"). BVI is a leading global developer, manufacturer, and marketer of specialized surgical devices for the ophthalmic marketplace. The sale is expected to close during the third quarter. Additional terms of the transaction were not disclosed.
Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that it has completed a growth investment in ELAP Services LLC. Headquartered in Wayne, Pa., ELAP specializes in reducing health insurance costs for mid-size companies across the United States.
Dynatronics Corporation, a manufacturer and distributor of advanced-technology medical devices and rehabilitation equipment for the physical therapy, sports medicine and related markets, announces the addition of two experienced sales managers to advance the Company's strategic plans to accelerate organic sales growth.
EndoStim Secures $25 Million in Funding to Expand Commercialization Efforts and Conduct a Pivotal U.S. Clinical Trial
EndoStim, Inc., a medical device company that has developed neurostimulation therapy for gastroesophageal reflux disease (GERD), today announced it has completed a Series D financing round of $25 million. Endeavour Vision, an internationally recognized investor in healthcare and technology companies, led the round, with participation from existing investors, led by Santé Ventures. New investors Wellington Partners and Gimv completed the syndicate.
Dynatronics Corporation, a manufacturer and marketer of rehabilitation and physical therapy products, today announced changes in senior management at the Company. Larry K. Beardall, Executive Vice-President of Marketing and Strategic Planning, will be leaving the Company's management team effective June 3, 2016. Mr. Beardall will also cease to serve as a member of the Board of Directors.
Abbott and St. Jude Medical, Inc. announced today a definitive agreement for Abbott to acquire St. Jude Medical, creating a premier medical device leader with top positions in high-growth cardiovascular markets, including atrial fibrillation, structural heart and heart failure as well as a leading position in the high-growth neuromodulation market.
Ascension, the nation's largest non-profit health system, has reached an agreement with TowerBrook Capital Partners, an investment management firm, designed to invest in and strategically develop the Ascension subsidiary TriMedx, an independent market leader in the provision of healthcare technology management services to both healthcare providers and medical equipment and device manufacturers. Under the agreement, TriMedx and several related subsidiaries will become an independent business owned by Ascension and TowerBrook through a new partnership vehicle.
Dynatronics Corporation, a manufacturer and distributor of advanced-technology medical devices and rehabilitation equipment for the physical therapy, sports medicine and related markets, announced the hiring of Thomas J. (Jeff) Gephart to fill the company's new position of Senior Vice President of Sales. Mr. Gephart will join the company's strategic management team and will report directly to CEO, Kelvyn Cullimore Jr.
Dynatronics Corporation, a manufacturer and marketer of rehabilitation and physical therapy products, today announced the appointment of David B. Holtz and election of Scott A. Klosterman as members of the company’s Board of Directors.
Dynatronics Corporation, a manufacturer and marketer of rehabilitation and physical therapy products, announced today the appointments of Erin Enright and Brian Larkin to its board of directors. This expansion of the board of directors was contemplated as part of the recent investment in Dynatronics led by Prettybrook Partners that closed on June 30, 2015.
Integra LifeSciences Holdings Corporation today announced that the Board of Directors of Integra has approved the separation of SeaSpine Holdings Corporation from Integra in the form of a tax-free dividend involving the distribution of all outstanding shares of SeaSpine common stock to holders of Integra common stock.
HealthEquity, Inc. (HQY), one of the largest U.S. health savings account (HSA) non-bank custodians, today announced the pricing of its previously announced follow-on public offering of 3,850,000 shares of common stock at a price to the public of $25.90 per share.
Use of Proceeds to Promote Organic Growth and Support Strategic Acquisitions
Digital Health Innovation in Context 2015 was a one day conference focused on the world of big data in digital health: strategy, opportunities, and innovation. The intimate conference setting featured an all star roster of healthcare executives, entrepreneurs, and investors.
Quanta Fluid Solutions Ltd, a pioneering developer of advanced haemodialysis systems, announces it has received CE mark for SC+, its portable, cartridge-based haemodialysis system.
First successful exit from the vintage 2013 Wellington Partners IV Life Science Fund less than 6 months after the initial investment.
Combination Creates a Leading U.S. Provider of Sports Medicine and Rehabilitative Orthopedic Products and Services
Owens & Minor, Inc. (NYSE:OMI) today announced that its board of directors has elected two healthcare industry veterans to serve on the company's board, effective October 30, 2013. The new board members are: Stuart M. Essig, 52, the former chief executive officer and current board chairman of Integra LifeSciences Holdings Corporation (NASDAQ: IART); and David S. Simmons, 49, chairman & chief executive officer of Pharmaceutical Product Development, LLC.
Medical Device and Robotics Visionary Frederic Moll, M.D., and Healthcare Banker & Chief Financial Officer Erin Enright to Join Board of Directors
Wellington Partners has appointed Stuart M. Essig as a new venture partner for the life science investment team. Essig currently serves as chairman of the board of directors of Integra Life Sciences, a NASDAQ-listed company he built during his tenure as CEO to more than $800 million in revenues and $1.6 billion in enterprise value.
Tigerlabs Launches First Healthcare IT Accelerator Program In The Heart Of The NJ Pharmaceutical Corridor
Princeton-Based Startup Accelerator Expands Entrepreneurial Co-Working Campus to include Tigerlabs Health, Offering Funding, Mentorship, Seminars, and Demo Day for Fresh Healthcare IT Innovators
Sports Medicine Leader Announces Appointment as it Focuses on Strategic Growth
Integra LifeSciences Announces Appointment of Peter Arduini as President and Chief Executive Officer; Stuart Essig Named Chairman of the Board
PLAINSBORO, N.J., Dec. 21, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its Board of Directors has made the following changes, all effective January 3, 2012. The Board appointed Peter Arduini as President and Chief Executive Officer. In addition, the Board elected Mr. Arduini to a newly-created position on the Board. Stuart Essig has been appointed as Executive Chairman of the Board. Richard Caruso, founder of Integra LifeSciences and its Chairman of the Board since its inception, will remain as a director of the company. Jack Henneman, the Company's Chief Financial Officer, will report to Mr. Arduini.
Stuart M. Essig, President and CEO of Integra Life Sciences Holdings Corporation, discusses how the growth of medical device companies is enabled by product innovation, new business creation, geographic expansion and acquisition and product development. He also speaks about accelerating the organic growth of Integra with an aggressive acquisition program.
New York, November 5, 2007 — InfuSystem Holdings, Inc. (OTCBB: HAPN, HAPNW, HAPNU), the leading provider of ambulatory infusion pump services for administering chemotherapy, today announced the appointment of Sean M. Whelan, CPA, to the position of chief financial officer. Mr. Whelan replaces Erin Enright who held the position through the successful completion of the InfuSystem acquisition.
WARSAW, Ind., March 22, 2005 /PRNewswire-FirstCall via COMTEX/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH), a leader in the orthopaedics industry, announced today that Stuart M. Essig, President and Chief Executive Officer of Integra LifeSciences Holdings Corporation, has been elected to the Company's Board of Directors.